secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProPhase Labs, Inc. (PRPH)
CIK:        0000868278
Form:       8-K
Filed at:   2025-07-25T23:59:59+00:00
Accession:  0001641172-25-020898
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

ProPhase Labs regains Nasdaq compliance after annual meeting; all director nominees elected
--------------------------------------------------------------------------------

- All four director nominees (Karkus, Gleckel, Hirsch, Abenante) elected; say-on-pay approved with 85.3% support.
- Stockholders selected 3-year frequency for say-on-pay; board adopts, next vote in 2028.
- Newly elected Abenante appointed to Audit Committee, making it three independent directors, regaining Nasdaq compliance.
- Company notified Nasdaq it has regained compliance with Rule 5605(c)(2)(A).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/868278/000164117225020898/0001641172-25-020898-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/868278/000164117225020898/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-020898

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer